Testing effectiveness (Phase 2)Study completedNCT05303376
What this trial is testing
Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 Illness
Who this might be right for
COVID-19
Immune Biosolutions Inc 123
Showing 20 of 0 results